About Sristi Suman Jayaswal
The stock market dynamics sparked Sristi's interest during her school days, which led her to become a financial journalist. Investing in undervalued stocks with solid long-term growth prospects is her preferred strategy.
Having earned a master's degree in Accounting and Finance, Sristi hopes to deepen her investment research experience and better guide investors.
Recent Articles By Sristi Suman Jayaswal
Should Investors Keep an Eye on JPMorgan and Citigroup (C) in 2024?
The banking sector has showcased commendable resilience and stability, defying the hurdles encountered at the beginning of 2023. Following a substantial resurgence in bank stocks, let’s examine whether investors should keep an eye on banking stocks Citigroup (C) and JPMorgan Chase (JPM) for 2024. Read on…
2024 Buy or Hold Real Estate Stocks?
Despite the persistence of high property prices and tight inventory levels, cooling mortgage rates may incentivize prospective homebuyers to kick-start their property search, suggesting the housing market might be bouncing back. To that end, let's explore whether to buy or hold real estate stocks CBRE Group (CBRE), Hang Lung Properties (HLPPY), and Guild Holdings (GHLD) for 2024. Read on…
3 Energy Stock Outliers With Massive Gain Potential
Given the accelerating global demand for oil and gas coupled with a dwindling supply, it's plausible that we may witness a significant surge in energy prices, which could stimulate considerable growth within the energy sector. To that end, fundamentally strong energy stocks ChampionX Corporation (CHX), Ultrapar Participações S.A. (UGP), and Star Group, L.P. (SGU) could be solid buys now. Read on…
4 A-Rated Biotech Stock Picks for 2024 Success
The biotechnology industry is experiencing significant growth, fueled by recent breakthroughs in drug development, technological innovations, and robust government support. Given this backdrop, promising biotech stocks Shionogi & Co. (SGIOY), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and United Therapeutics Corporation (UTHR) could be solid buys for 2024 success. Also, these stocks are A-rated (Strong Buy) in our proprietary rating system. Read on…
3 Publishing Stocks to Watch in 2024
The increased incorporation of digital technology continues to be a crucial catalyst propelling sustained resilience within the publishing industry, ensuring its stability through the foreseeable future. To that end, let’s explore publishing stocks RELX PLC (RELX), Lee Enterprises (LEE), and The New York Times (NYT), which could be added to the watchlist for 2024. Read on…
2024 Software Outlook: Buying Potential for 3 Stocks
The software industry, witnessing significant expansion, is driven by technological advancements, digital transformations across diverse sectors, and the mounting focus on data-oriented solutions. Given this backdrop, quality software stocks Semrush Holdings (SEMR), Dynatrace (DT), and Progress Software (PRGS) could be solid buys now. Read on…
3 A-Rated Oil & Gas Stocks to Buy for December
The energy sector is capitalizing on a robust demand, augmented by an escalation in domestic gas utilization. Therefore, quality oil and gas stocks Martin Midstream Partners L.P. (MMLP), CrossAmerica Partners LP (CAPL), and Star Group, L.P. (SGU) could be solid buys for December. Also, these stocks are A-rated (Strong Buy) in our proprietary rating system. Read more…
5 Waste Disposal Stocks Bursting With Potential Gains
The global waste management industry is undergoing significant transformation due to increased ecological consciousness and technological advancements. Given this backdrop, quality waste disposal stocks Waste Management (WM), Ecolab (ECL), Clean Harbors (CLH), Republic Services (RSG), and Concrete Pumping Holdings (BBCP), bursting with potential gains, could be solid buys now. Read on…
3 Biotech Stock Buys to Supercharge Your Portfolio
The biotechnology industry is flourishing due to the recent breakthroughs in drug development, technological advancements, and strong governmental backing. Given this backdrop, promising biotech stocks Organogenesis Holdings (ORGO), Theratechnologies (THTX), and Vertex Pharmaceuticals (VRTX) could be solid buys to supercharge the portfolios. Read on…